# Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

> **NCT00630357** · PHASE4 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 14 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Levetiracetam (Keppra)

## Key facts

- **NCT ID:** NCT00630357
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2013-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630357, "Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00630357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*